gastroduodenal ulcers
The incidence of        endoscopically determined gastroduodenal ulcers in placebo-treated patients was 4       (4%) of 99, and the incidences across all dosages of celecoxib were not       significantly different (P>.40): 9 (6%) of 148 with 100 mg twice per day, 6 (4%)        of 145 with 200 mg twice per day, and 8 (6%) of 130 with 400 mg twice per day.
The incidence of        endoscopically determined  @SUBJECT$   @PREDICAT$  placebo-treated  @OBJECT$  was 4       (4%) of 99, and the incidences across all dosages of celecoxib were not       significantly different (P>.40): 9 (6%) of 148 with 100 mg twice per day, 6 (4%)        of 145 with 200 mg twice per day, and 8 (6%) of 130 with 400 mg twice per day.